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Fig 2. Completion digital subtraction angiography showing successful
embolization of bilateral renal arteriovenous malformations (AVMs).
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Is Left Renal Vein Ligation Benign? A Novel Method for Maintaining
Left Renal Venous Outﬂow During Extensive Inferior Vena Caval
Resection.
Charles S. Kiell, Andrew R. Barksdale. St Francis Hospital, Indianapolis, Ind
Introduction: Ligation of the left renal vein (LRV) has been felt to be
a relatively benign maneuver, with renal venous outﬂow maintained
through existing venous branches. LRV has shown to be of negligible in
long-term renal function in the setting of aneurysm repair with dual kidneys;
the effect of LRV in the setting of a solitary left kidney, however, is less well
described. Case reports, primarily in the urology literature, have described
sudden deterioration in renal function with LRV during right nephrectomy,
and hence, the consequences of acute LRV might better be described as
“unpredictable.” This report describes a patient who suffered rapid renal
deterioration from left renal vein obstruction secondary to recurrent renal
cell carcinoma, underwent extensive inferior vena cava (IVC) resection,
and on whom a novel method for intraoperative maintenance of left renal
venous drainage during level III vena caval resection was used.
Methods: The patient, a 62-year-oldman evaluated for rapidly progres-
sive lower extremity edema, had undergone laparoscopic right nephrectomy
9 years earlier without venous or extrarenal spread. An echocardiogram noted
amass in the IVC, and subsequentmagnetic resonance imaging demonstrated
a suspected recurrent tumor involving the IVCandextending to the levelof the
right hepatic vein. Creatinine had concomitantly risen from 1.2 to 2.9mg/dL
during an8-day period.The left renal veinwas patent,with someﬂow into IVC
alongwith patent left gonadal, adrenal, and lumbar veins. Results of ametasta-
tic survey were negative. The patient was offered IVC resection. Exposure was
performed through a right thoracoabdominal incision, with conﬁrmation of
tumor extent and absence of metastases. The left renal vein was extensively
mobilized, andcaval resection and reconstruction from theL3 level to right he-
patic veinwas planned. A venovenous circuit was created using percutaneously
placed cannulas in the right common femoral and right internal jugular veins.
With concerns for further compromise of renal function from even temporary
renal vein occlusion, a 24F right-angle single-stage venous cannula was placed
in the left renal vein, and bypass with left renal vein decompression was insti-
tuted using full-heparinization. Potentially curative resection was performeduneventfully, and the IVC was reconstructed using a 24-mm Dacron graft
with a 10-mm sidearm left renal graft. Total bypass time was 139 minutes,
and urine output during the bypass period was 240 mL.
Results: Excellent urine output was seen throughout the periopera-
tive period, with creatinine returning to value of 1.1 mg/dL by postopera-
tive day 5. The patient was discharged on postoperative day 7. Postoperative
venous-phase computed tomography has demonstrated patent IVC and left
renal vein interposition grafts.
Conclusions: The effect of LRV with a solitary left kidney is unpredict-
able; the negligible effects of LRV after aneurysm repairmay bemore an effect
of right kidney compensation rather than a reﬂectionon the benignity of LRV.
When planning pararenal vena caval resection and reconstruction, reconstruc-
tion of the left renal vein is advisable, and intraoperative renal function can be
optimized using the renal vein drainage technique described above.
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Endostaples for Distal Fixation in a Thoracic Endovascular Aortic
Aneurysm Repair (TEVAR)
Ratna C. Medicherla, Evan Lipsitz. Monteﬁore Medical Center, Bronx, NY
Introduction: We report the case of 77-year-old woman with an
asymptomatic enlarging distal thoracic aortic aneurysm (TAA) treated
with endovascular repair using endostaples.
Methods: The patient was a former smoker with a history of hyper-
tension, chronic kidney disease, asthma, and hypothyroidism. Physical ex-
amination was signiﬁcant for a pulsatile mass in the midabdomen. She was
followed up with serial computed tomography angiography (CTA) for
5 years. The TAA measured 3.8 cm in 2009, enlarging to 5.5 cm in
2013. CTA revealed a short distal neck w5 mm proximal to the celiac
axis. Therefore, the decision was made to use endostaples for distal ﬁxation.
Results: After informed consent, the patient was taken to the operating
room. A 7F sheath was inserted via a right femoral exposure. The left common
femoral artery was accessed percutaneously. An aortogram conﬁrmed a short
distal neck. The celiac artery was selected with a guidewire, and access was main-
tained in the hepatic artery with a glide catheter. A Cook Zenith TX2 28-mm
80-mmendograft (CookMedical, Bloomington, Ind)was deployed. FourAptus
Heli-FXThoracic EndoAnchors (AptusEndosystems Inc, Sunnyvale,Calif) were
placed at 2, 4, 8, and 10 o’clock. A completion angiogram showed no endoleak
and good ﬁlling of the celiac artery. The patient tolerated the procedure well,
without any complications. She was discharged the next day, and remained well
at the 2-month follow-up. A CTA at the 2-month follow-up conﬁrmed good
placementofgraft,withnoendoleak, and theaneurysmwascompletely excluded.
Conclusions: There are multiple options for obtaining distal ﬁxation
during thoracic endovascular aortic repair. These include coverage of the ce-
liac axis, barbs/hooks on the graft, distal graft visceral uncovered bare-metal
stents, fenestrated/scalloped stent grafts, branched endografts, parallel stent-
ing (chimney, snorkel, or periscope), and endoanchors, endostaples, and
endoscrews. This case is an example of a distal TAA with difﬁcult anatomy
due to a short distal neck treated with endovascular repair using endostaples
to ensure distal ﬁxation and reduce the risk of migration. Endostaples can
serve as a safe and viable alternative that is minimally invasive for handling
short landing zones. Early results with endostaples are promising, but further
studies are warranted to evaluate long-term safety and durability. The AN-
CHOR registry is designed to evaluate patients from multiple sites treated
with the Aptus Heli-FX EndoAnchor System and is currently enrolling.
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Current Accepted Hemodynamic Criteria for Critical Limb Ischemia
(CLI) Do Not Accurately Stratify Patients at High Risk for Limb Loss
Raghuveer Vallabhaneni, Corey A. Kalbaugh, Ana Kouri, Mark A. Farber,
William A. Marston. University of North Carolina-Chapel Hill, Chapel
Hill, NC
Introduction: Critical limb ischemia (CLI) has been deﬁned as pa-
tients with rest pain or tissue loss who have an ankle pressure (AP)
<70 mm Hg or toe pressure (TP) <50 mm Hg. Data suggesting these pa-
tients are at high risk for limb loss without successful revascularization are
limited. This study was designed to identify limb loss and mortality rates
in patients who did not respond to revascularization or who were not revas-
cularized and to determine whether CLI hemodynamic criteria accurately
identify patients at high risk for limb loss.
Methods: Between 2008 and 2010, all patients undergoing lower ex-
tremity arterial duplex testing at our hospital were identiﬁed. Those with an
AP <70 mmHg or TP <50 mm Hg were retrospectively reviewed to deter-
mine whether they had symptoms of rest pain or tissue loss qualifying them
for analysis in the database. Patients who underwent revascularization and
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criteria were removed from the cohort. Demographic factors, wound heal-
ing, amputation rates, and mortality were obtained and analyzed in relation
to the initial APs and TPs. Outcomes were measured using Kaplan-Meier
life-table analysis and Cox proportional hazards models.
Results: CLI criteria were identiﬁed in 443 limbs of 381 patients. Af-
ter revascularization, 98 limbs with AP or TP, or both, improved to
>70 mm Hg and 50 mm Hg were removed from the study cohort. In
45 limbs, patients did not respond to the intial revascularization and their
APs or TPs, or both, remained within CLI criteria. These limbs remained
in the patient cohort, yielding a ﬁnal group of 296 patients and 345 limbs.
Mean follow-up time was 2.0 years. In the entire patient cohort, limb loss
occurred in 24% at 1 year and in 31% at 3 years. Mortality was 32% at
1 year and 56% at 3 years. Amputation-free survival was 54% at 1 year
and 28% at 3 years. Lower TPs were associated with a signiﬁcantly higher
incidence of amputation. Among the 85 with an initial TP #10 mm Hg,
limb loss occurred in 46% at 1 year and in 60% at 3 years. This limb loss
was signiﬁcantly greater than limb loss of 18% at 3 years among the 115
with a TP of 31 to 50 mm Hg (P < .001, Fig). Amputation-free survival
in patients with a TP #10 mm Hg was 8% at 3 years.
Conclusions: CLI is associated with a high mortality, but not all pa-
tients with currently deﬁned hemodynamic criteria for CLI are at high risk
of limb loss. Patients with a TP between 31 and 50 mm Hg (41% of the
cohort) and not receiving revascularization or not responding hemodynam-
ically to revascularization experienced a low risk of limb loss. We recommend
revising the hemodynamic criteria for CLI to better identify patients at high
risk for limb loss who require intervention to improve outcomes.Fig. Limp salvage by toe hemodynamic pressure groups.
Fig. Primary patency: Percutaneous transluminal angioplasty (PTA) vs
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Primary Stent Placement Improves Patency After Endovascular
Treatment of Hepatic Artery Stenosis Following Liver Transplantation
Linda Le, William Terral, Nicolas Zea, Hernan A. Bazan, Taylor A. Smith,
George E. Loss, Edward Bluth, W. Charles Sternbergh III. Ochsner Clinic,
New Orleans, La
Introduction: Signiﬁcant hepatic artery stenosis (HAS) after ortho-
topic liver transplantation (OLT) can lead to thrombosis with subsequent
liver failure in 30% of patients. Although operative intervention or retrans-
plantation has been the traditional solution, endovascular therapy has
emerged as a less invasive treatment strategy. Prior smaller studies have
been conﬂicting in the relative efﬁcacy of percutaneous transluminal angio-
plasty (PTA) vs primary stent placement for HAS.
Methods: This was a single-center retrospective review of all endovas-
cular interventions for HAS after OLT during a 54-month period (August
2009-December 2013). Patients with ultrasound evidence of severe HAS
(peak systolic velocity >400 cm/s, resistive index of <0.5, tardus parvus
spectral abnormalities) underwent endovascular treatment with primary
stent placement or PTA. Outcomes calculated were technical success, pri-
mary and primary assisted patency rates, reinterventions, and complications.
Results: Sixty-two interventions for HAS were performed in 42 pa-
tients with a mean follow-up of 19.1 6 15.2 months. During the study
period, the rate of treated HAS was 6.4% (42 of 654). Primary technical suc-
cess was achieved in 95% (59 of 62) of cases. Initial treatment was with PTA
alone (n ¼ 16) or primary stent (n ¼ 26). Primary patency rates after initialstent placement were 91%, 81.3%, 77%, and 77% at 1, 6, 12, and 24 months,
respectively, and signiﬁcantly better (P ¼ .01) compared with 68.8%, 57.1%,
44% for initial PTA (Fig). There were 20 reinterventions in 14 patients
(eight stents, six PTAs) for recurrent HAS. The time to initial reintervention
in patients with PTA alone vs initial stent was 51 and 105.8 days, respec-
tively. Stent placement was required in 75% of reinterventions, of which
ﬁve drug-eluting stents were placed. Overall Kaplan-Meier primary patency
rates were 82%, 70%, 63%, and 50% at 1, 6, 12, and 24 months, respectively.
Overall primary-assisted patency was 96% at 12 months and 93% at
24 months. Major complications were one arterial rupture treated endovasc-
ularly and two hepatic artery dissections. Long-term risk of HAT in the
entire patient cohort was 4.8%.
Conclusions: In this series, which represents the largest reported
cohort of endovascular interventions for HAS to date, we demonstrate
that HAS after OLT can be treated endovascularly with high initial technical
success and excellent primary assisted patency. Initial stent placement signif-
icantly decreased the need for reintervention. Avoidance of HAT is possible
in >95% of patients with endovascular treatment and close follow-up.Author Disclosures: L. Le: None;W. Terral: None;N. Zea: None;H. A.
Bazan: None; T. A. Smith: None; G. E. Loss: None; E. Bluth: None;W.
C. Sternbergh: None.
Validated Prediction of Groin Infection After Revascularization
Procedures
Kyla M. Bennett, Howard Levinson, John E. Scarborough, Cynthia K.
Shortell. Duke University Medical Center, Durham, NC
Introduction: Groin wound infection is a costly and morbid event af-
ter lower extremity revascularization. To date, a comprehensive and vali-
dated method for identifying patients who are at greatest risk for this
complication, and who might therefore beneﬁt from prophylactic muscle
ﬂap coverage of their initial groin incision, has yet to be developed.
Methods: Our retrospective analysis included all patients at a single
institution who underwent lower extremity revascularization in which a
groin incision was used from 2009 through 2012. Patients were randomly
divided into two groups matched for operative year and surgeon: a pilot
group, which was used to develop a predictive model for our primary
outcome, and a validation group, which was used to test that model. The
primary outcome for our analysis was groin wound infection requiring oper-
ative intervention. Potential predictor variables included patient age, sex,
year of operation, previous groin incision, use of thrombolytic agents,
concomitant amputation, body mass index, smoking status, diabetes melli-
tus, end-stage renal disease, malnutrition, preoperative wound, type of
conduit, level of distal target vessel, and emergency status of the index oper-
ation. Best-ﬁt model selection methods were used to evaluate all possible
combinations, interactions, and transformation of potential predictor vari-
ables from the pilot patient group. The resulting model with the lowest
Akaike information criterion was selected for testing using the validation pa-
tient group. A user-friendly computer program was developed that uses this
model to predict an individual patient’s risk of operative groin wound
infection.
Results: The study included 284 patients, 141 in the pilot group and
144 in the validation group, who underwent lower extremity revasculariza-
tion procedures. Seventeen patients (12.1%) from the pilot group developed
groin incision infection that required operation. The predictive model that
